About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Histograft
Betuvax
Nextgen
Gemabank
Genetico
Biotechnology Developments
Genotarget
Reprobank
Vitacel
05.12.2024
Press releases
The first patients received injections of a new drug for interstitial cystitis
11.11.2024
Press releases
Gemabank’s cryostorage facility has been expanded to include 25,000 additional places
07.11.2024
Press releases
Artgen Biotech’s shares are available for trading on the Saint Petersburg Stock Exchange
06.11.2024
Press releases
The number of IVF cycles using PGT in Russia increased by 25%
01.11.2024
Press releases
Artgen Biotech’s performance for 9 months of 2024 according to RAS
30.10.2024
Press releases
Genetico’s performance for 9 months of 2024 according to RAS
29.10.2024
Press releases
Gemabank’s results for 9 months of 2024 according to RAS
1
2
3
4
…
17
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
